Brief: Homology Medicines Inc says On February 22, A Purported Homology Stockholder Filed A Complaint In Court Against Co And Members Of Its Board
March 11 (Reuters) - Homology Medicines Inc FIXX.O :
* HOMOLOGY MEDICINES INC - ON FEBRUARY 22, A PURPORTED
HOMOLOGY
STOCKHOLDER FILED A COMPLAINT IN COURT AGAINST CO AND MEMBERS OF
ITS BOARD
* HOMOLOGY MEDICINES-BELIEVES PROXY STATEMENT/PROSPECTUS
COMPLIES
FULLY WITH ALL APPLICABLE LAW AND ALLEGATIONS IN COMPLAINT ARE
"WITHOUT MERIT"
Further company coverage: FIXX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview